Gavreto

Gavreto Indications/Uses

pralsetinib

Manufacturer:

CStone

Distributor:

DCH Auriga - Healthcare

Marketer:

DCH Auriga - Healthcare

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Indications/Uses

GAVRETO is indicated for the treatment of adult patients with metastatic RET fusion-positive non-small cell lung cancer (NSCLC).

Sign up for Free to Continue Reading

Continue with Google

Sign Up With Email

Already a member? Sign In